Draft guidance the US Food and Drug Administration issued 25 October outlines how and why pharmaceutical companies should prepare to accept requests to host remote interactive evaluations at their manufacturing facilities.
Such evaluations by the FDA and other regulatory agencies, which can include screensharing and video walk-throughs, became popular during the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?